Core Laboratories Nv Stock Analysis
CLB Stock | USD 17.75 0.79 4.26% |
Core Laboratories NV is overvalued with Real Value of 16.86 and Target Price of 19.33. The main objective of Core Laboratories stock analysis is to determine its intrinsic value, which is an estimate of what Core Laboratories NV is worth, separate from its market price. There are two main types of Core Laboratories' stock analysis: fundamental analysis and technical analysis.
The Core Laboratories stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Core Laboratories' ongoing operational relationships across important fundamental and technical indicators.
Core |
Core Stock Analysis Notes
About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Core Laboratories was currently reported as 5.34. The company has Price/Earnings To Growth (PEG) ratio of 1.66. Core Laboratories last dividend was issued on the 4th of November 2024. The entity had 2:1 split on the 9th of July 2010. Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States. For more info on Core Laboratories NV please contact Lawrence Bruno at 713 328 2673 or go to https://www.corelab.com.Core Laboratories Quarterly Total Revenue |
|
Core Laboratories Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Core Laboratories' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Core Laboratories NV or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Core Laboratories generated a negative expected return over the last 90 days | |
Core Laboratories is unlikely to experience financial distress in the next 2 years | |
Over 99.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from news.google.com: Core Labs Delivers Mixed Q4 Heres Why The Free Cash Flow Explosion Matters - StockTitan |
Core Laboratories Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Core Laboratories previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
31st of January 2024 Upcoming Quarterly Report | View | |
24th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
31st of January 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Core Largest EPS Surprises
Earnings surprises can significantly impact Core Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2022-04-27 | 2022-03-31 | 0.09 | 0.08 | -0.01 | 11 | ||
2003-05-09 | 2003-03-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2002-05-07 | 2002-03-31 | 0.06 | 0.05 | -0.01 | 16 |
Core Laboratories Environmental, Social, and Governance (ESG) Scores
Core Laboratories' ESG score is a quantitative measure that evaluates Core Laboratories' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Core Laboratories' operations that may have significant financial implications and affect Core Laboratories' stock price as well as guide investors towards more socially responsible investments.
Core Laboratories Thematic Classifications
In addition to having Core Laboratories stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Petroleum and Natural GasUSA Equities from Petroleum and Natural Gas industry as classified by Fama & French |
Core Stock Institutional Investors
Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 819.6 K | Btim Corp | 2024-12-31 | 617.3 K | Fred Alger Management, Llc | 2024-09-30 | 535.9 K | Charles Schwab Investment Management Inc | 2024-09-30 | 529.5 K | Northern Trust Corp | 2024-09-30 | 499.6 K | Bank Of New York Mellon Corp | 2024-09-30 | 478 K | Gendell Jeffrey L | 2024-09-30 | 460.7 K | Van Eck Associates Corporation | 2024-09-30 | 417.4 K | Ameriprise Financial Inc | 2024-09-30 | 337.9 K | Ariel Investments, Llc | 2024-09-30 | 10 M | Blackrock Inc | 2024-09-30 | 7.8 M |
Core Market Capitalization
The company currently falls under 'Small-Cap' category with a total capitalization of 833.36 M.Core Profitablity
The company has Net Profit Margin of 0.05 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.12 %, which entails that for every 100 dollars of revenue, it generated $0.12 of operating income.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.07 | 0.07 | |
Return On Capital Employed | 0.10 | 0.09 | |
Return On Assets | 0.06 | 0.10 | |
Return On Equity | 0.19 | 0.32 |
Management Efficiency
Core Laboratories has Return on Asset of 0.0589 % which means that on every $100 spent on assets, it made $0.0589 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1116 %, implying that it generated $0.1116 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At present, Core Laboratories' Return On Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.32, whereas Return On Tangible Assets are forecasted to decline to 0.07. At present, Core Laboratories' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 26 M, whereas Total Assets are forecasted to decline to about 550.2 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 4.43 | 2.64 | |
Tangible Book Value Per Share | 3.04 | 3.19 | |
Enterprise Value Over EBITDA | 13.10 | 12.62 | |
Price Book Value Ratio | 3.30 | 6.42 | |
Price Fair Value | 3.30 | 6.42 | |
Enterprise Value Multiple | 13.10 | 12.62 | |
Enterprise Value | 4.5 B | 2.7 B |
The decision-making processes within Core Laboratories are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Technical Drivers
As of the 31st of January, Core Laboratories shows the Standard Deviation of 2.65, risk adjusted performance of (0.01), and Mean Deviation of 2.03. Core Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Core Laboratories Price Movement Analysis
The output start index for this execution was fourty-four with a total number of output elements of seventeen. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Core Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Core Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Core Laboratories Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Core Laboratories Outstanding Bonds
Core Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Core Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Core bonds can be classified according to their maturity, which is the date when Core Laboratories NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Core Laboratories Predictive Daily Indicators
Core Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Core Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 60943.29 | |||
Daily Balance Of Power | (0.49) | |||
Rate Of Daily Change | 0.96 | |||
Day Median Price | 17.87 | |||
Day Typical Price | 17.83 | |||
Price Action Indicator | (0.51) | |||
Period Momentum Indicator | (0.79) |
Core Laboratories Corporate Filings
8K | 29th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 2nd of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
14th of November 2024 Other Reports | ViewVerify | |
13th of November 2024 Other Reports | ViewVerify | |
10Q | 24th of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 23rd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Core Laboratories Forecast Models
Core Laboratories' time-series forecasting models are one of many Core Laboratories' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Core Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Core Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Core Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Core shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Core Laboratories. By using and applying Core Stock analysis, traders can create a robust methodology for identifying Core entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.09 | 0.11 | |
Operating Profit Margin | 0.11 | 0.14 | |
Net Profit Margin | 0.06 | 0.08 | |
Gross Profit Margin | 0.17 | 0.20 |
Current Core Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Core analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Core analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
19.33 | Hold | 6 | Odds |
Most Core analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Core stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Core Laboratories, talking to its executives and customers, or listening to Core conference calls.
Core Stock Analysis Indicators
Core Laboratories NV stock analysis indicators help investors evaluate how Core Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Core Laboratories shares will generate the highest return on investment. By understating and applying Core Laboratories stock analysis, traders can identify Core Laboratories position entry and exit signals to maximize returns.
Begin Period Cash Flow | 15.4 M | |
Long Term Debt | 163.1 M | |
Common Stock Shares Outstanding | 47.5 M | |
Total Stockholder Equity | 224.8 M | |
Tax Provision | 4.2 M | |
Quarterly Earnings Growth Y O Y | 0.316 | |
Property Plant And Equipment Net | 153.5 M | |
Cash And Short Term Investments | 15.1 M | |
Cash | 15.1 M | |
Accounts Payable | 33.5 M | |
Net Debt | 200.3 M | |
50 Day M A | 19.1376 | |
Total Current Liabilities | 88.1 M | |
Other Operating Expenses | 455.1 M | |
Non Current Assets Total | 363.3 M | |
Forward Price Earnings | 19.7239 | |
Non Currrent Assets Other | 98.6 M | |
Stock Based Compensation | 14 M |
Complementary Tools for Core Stock analysis
When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |